COLLECTIONS
WORKFLOWS

SOLVE FSHD is a venture philanthropic organization dedicated to funding innovative biotech and biopharma research and development activities. Their mission is to accelerate novel treatments for facioscapulohumeral muscular dystrophy (FSHD) and they aim to find a cure by 2027. The organization was founded with a generous commitment of $100M USD from the Wilson family.
Focus Areas
Investment Types
Notable Investments